The newly-founded Oxford cardiovascular imaging spinout raised seed funding from backers including Oxford Sciences Innovation to pursue further product development.

Caristo Diagnostics, a UK-based cardiovascular imaging software spinout from University of Oxford, launched publicly yesterday with £2m ($2.6m) of seed money from investors including Oxford Sciences Innovation, the university’s venturing fund. The round also featured Oxford Technology Investment Fund and venture capital firm Longwall Ventures. Founded in June 2018, Caristo Diagnostics is working on imaging…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.